Cellular and Mitochondrial Pathways Contribute to SGLT2 Inhibitors-mediated Tissue Protection: Experimental and Clinical Data

被引:4
作者
Sanz, Raul Lelio [1 ]
Menendez, Sebastian Garcia [1 ,2 ]
Inserra, Felipe [3 ]
Ferder, Leon [3 ]
Manucha, Walter [1 ,2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, Dept Patol Pharmacol, Inst Med & Biol Expt Cuyo, IMBECU, RA-5500 Mendoza, Argentina
[2] Univ Nacl Cuyo, Fac Ciencias Med, Dept Patol & Pharmacol, Lab Farmacol Expt Bas & Traslac,Area Farmacol, RA-5500 Mendoza, Argentina
[3] Univ Maimonides, Dept Pathol & Pharmacol, C1405, Buenos Aires, Argentina
关键词
SGLT2i; cardiovascular diseases; sirtuins; oxidative stress; inflammation; mitochondrial dysfunction; ANGIOTENSIN-II; MECHANISMS; SIRTUINS; INFLAMMATION; DAMAGE; METABOLISM; ACTIVATION; BENEFITS; OBESITY; HEART;
D O I
10.2174/0113816128289350240320063045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In metabolic syndrome and diabetes, compromised mitochondrial function emerges as a critical driver of cardiovascular disease, fueling its development and persistence, culminating in cardiac remodeling and adverse events. In this context, angiotensin II - the main interlocutor of the renin-angiotensin-aldosterone system - promotes local and systemic oxidative inflammatory processes. To highlight, the low activity/expression of proteins called sirtuins negatively participates in these processes, allowing more significant oxidative imbalance, which impacts cellular and tissue responses, causing tissue damage, inflammation, and cardiac and vascular remodeling. The reduction in energy production of mitochondria has been widely described as a significant element in all types of metabolic disorders. Additionally, high sirtuin levels and AMPK signaling stimulate hypoxia-inducible factor 1 beta and promote ketonemia. Consequently, enhanced autophagy and mitophagy advance through cardiac cells, sweeping away debris and silencing the orchestra of oxidative stress and inflammation, ultimately protecting vulnerable tissue from damage. To highlight and of particular interest, SGLT2 inhibitors (SGLT2i) profoundly influence all these mechanisms. Randomized clinical trials have evidenced a compelling picture of SGLT2i emerging as game-changers, wielding their power to demonstrably improve cardiac function and slash the rates of cardiovascular and renal events. Furthermore, driven by recent evidence, SGLT2i emerge as cellular supermolecules, exerting their beneficial actions to increase mitochondrial efficiency, alleviate oxidative stress, and curb severe inflammation. Its actions strengthen tissues and create a resilient defense against disease. In conclusion, like a treasure chest brimming with untold riches, the influence of SGLT2i on mitochondrial function holds untold potential for cardiovascular health. Unlocking these secrets, like a map guiding adventurers to hidden riches, promises to pave the way for even more potent therapeutic strategies
引用
收藏
页码:969 / 974
页数:6
相关论文
共 74 条
  • [1] Identification and characterization of a functional mitochondrial angiotensin system
    Abadir, Peter M.
    Foster, D. Brian
    Crow, Michael
    Cooke, Carol A.
    Rucker, Jasma J.
    Jain, Alka
    Smith, Barbara J.
    Burks, Tyesha N.
    Cohn, Ronald D.
    Fedarko, Neal S.
    Carey, Robert M.
    O'Rourke, Brian
    Walston, Jeremy D.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (36) : 14849 - 14854
  • [2] A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis
    Ahn, Bong-Hyun
    Kim, Hyun-Seok
    Song, Shiwei
    Lee, In Hye
    Liu, Jie
    Vassilopoulos, Athanassios
    Deng, Chu-Xia
    Finkel, Toren
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (38) : 14447 - 14452
  • [3] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1451 - 1461
  • [4] The Renin Angiotensin Aldosterone System in Obesity and Hypertension Roles in the Cardiorenal Metabolic Syndrome
    Cabandugama, Peminda K.
    Gardner, Michael J.
    Sowers, James R.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2017, 101 (01) : 129 - +
  • [5] AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
    Canto, Carles
    Gerhart-Hines, Zachary
    Feige, Jerome N.
    Lagouge, Marie
    Noriega, Lilia
    Milne, Jill C.
    Elliott, Peter J.
    Puigserver, Pere
    Auwerx, Johan
    [J]. NATURE, 2009, 458 (7241) : 1056 - U140
  • [6] SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
    Chino, Yukihiro
    Samukawa, Yoshishige
    Sakai, Soichi
    Nakai, Yasuhiro
    Yamaguchi, Jun-ichi
    Nakanishi, Takeo
    Tamai, Ikumi
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (07) : 391 - 404
  • [7] Obese Adipocytes Have Altered Redox Homeostasis with Metabolic Consequences
    Cinti, Saverio
    [J]. ANTIOXIDANTS, 2023, 12 (07)
  • [8] Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases
    Dato, Virginia Actis
    Lange, Stephan
    Cho, Yoshitake
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [9] Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition
    de Cavanagh, Elena M. V.
    Inserra, Felipe
    Ferder, Leon
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 309 (01): : H15 - H44
  • [10] Fibroblast growth factor 21 attenuates ventilator-induced lung injury by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway
    Ding, Peng
    Yang, Rui
    Li, Cheng
    Fu, Hai-Long
    Ren, Guang-Li
    Wang, Pei
    Zheng, Dong-Yu
    Chen, Wei
    Yang, Li-Ye
    Mao, Yan-Fei
    Yuan, Hong-Bin
    Li, Yong-Hua
    [J]. CRITICAL CARE, 2023, 27 (01)